|Articles|May 15, 2015
FDA Comments on Continuous Manufacturing
Advertisement
Christine Moore, acting director in the Office of Process and Facilities at at FDA's Center for Drug Evaluation and Research, spoke with Pharmaceutical Technology at Interphex 2015 about advances in continuous manufacturing, regulatory concerns, and next steps.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
2
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
3
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
4
Is Pharma Solving the Right Problem with its Data Transformation Efforts?
5
